Zynex Stock Price, News & Analysis
Company Description
Zynex (OTC Link: ZYXIQ) is a publicly traded medical distribution company in the Healthcare sector. The company has a market capitalization of $1.7M.
ZYXIQ stock has declined 57.8% over the past year. Shares last traded at $0.0550.
On a trailing twelve-month basis, Zynex reported revenue of $192.4M with net income of $3.0M and diluted earnings per share of $0.09. The company operates at a net profit margin of 1.6%.
This page provides a comprehensive overview of ZYXIQ stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Zynex (ZYXIQ) stock last traded at $0.0550. Over the past 12 months, the stock has lost 57.8%. At a market capitalization of $1.7M, ZYXIQ is classified as a micro-cap stock with approximately 30.8M shares outstanding.
ZYXIQ Rankings
Latest News
Zynex has 1 recent news article. Of the recent coverage, 1 article coincided with positive price movement and 0 with negative movement. View all ZYXIQ news →
SEC Filings
Zynex has filed 10 recent SEC filings, including 6 Form 8-K, 2 Form 4, 2 Form 15-12G. The most recent filing was submitted on March 27, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all ZYXIQ SEC filings →
Financial Highlights
Zynex generated $192.4M in revenue over the trailing twelve months, retaining a 79.5% gross margin, operating income reached $6.0M (3.1% operating margin), and net income was $3.0M, reflecting a 1.6% net profit margin. Diluted earnings per share stood at $0.09. The company generated $12.7M in operating cash flow. With a current ratio of 4.46, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in Zynex (ZYXIQ) currently stands at 1.2 million shares, up 1.0% from the previous reporting period, representing 7.5% of the float. Over the past 12 months, short interest has decreased by 36.7%. The 7.8 days to cover indicates moderate liquidity for short covering.
Days to Cover History
Days to cover for Zynex (ZYXIQ) currently stands at 7.8 days, down 14% from the previous period. This moderate days-to-cover ratio suggests reasonable liquidity for short covering, requiring about a week of average trading volume. The days to cover has increased 681% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 9.1 days.
ZYXIQ Company Profile & Sector Positioning
Zynex (ZYXIQ) operates in the Medical Distribution industry within the broader Healthcare sector and is listed on the OTC Link.